Del Carmen Jeffrey 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Nov 28, 2025
Insider Transaction Report
Form 4
Del Carmen Jeffrey
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock, par value $0.001 per share
2025-11-26$4.21/sh+10,983$46,238→ 14,945 total - Sale
Common Stock, par value $0.001 per share
2025-11-26$23.33/sh−10,983$256,244→ 3,962 total - Exercise/Conversion
Options to purchase common stock
2025-11-26+10,983→ 1,053,552 totalExercise: $4.21Exp: 2027-01-06→ Common Stock (10,983 underlying)
Footnotes (3)
- [F1]Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
- [F2]Shares were sold in various lots from $23.331 to $23.345 per share. The price listed represents a weighted average price for the shares sold.
- [F3]Options previously vested in three annual tranches beginning on January 6, 2021.